ATRX (ATRX) Stock Price & Analysis
ATRX (ATRX) rose 0.00% to USD 0 as of June 10, 2026 at 03:30 UTC, according to Nexqual real-time market data.
ATRX last closed at USD 0; the session ranged USD 0–0 on volume of 84,001 shares. Market capitalization is $722, with a 52-week range of USD 0–0.01 (PNK). Source: Nexqual, June 10, 2026 at 03:30 UTC.
Key Statistics (as of June 10, 2026 at 03:30 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 84,001 shares |
| Market Cap | $722 |
| Exchange | PNK |
Technical Analysis (ATRX)
Nexqual's technical model rates ATRX "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:30 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (ATRX)
Wall Street analysts rate ATRX "None", per Nexqual as of June 10, 2026 at 03:30 UTC.
| Consensus Rating | None |
|---|
Earnings (ATRX)
Source: Nexqual, June 10, 2026 at 03:30 UTC.
Financials & Fundamentals (ATRX)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0 |
| Total Cash | $32,388 |
| Total Debt | $10.83M |
| Free Cash Flow | $563,753 |
Source: Nexqual, June 10, 2026 at 03:30 UTC.
Financial Health Score (ATRX)
Nexqual rates ATRX's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:30 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $32K cash vs $11M debt |
| Cash Flow | Weak — Operating cash flow -$714K |
| Efficiency | Mixed — No data |
Ownership (ATRX)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 7.22M |
| Float | 6.70M |
| Short % of Float | +3.93% |
Source: Nexqual, June 10, 2026 at 03:30 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BCII | BCII Enterprises Inc. | USD 0.01 | ▲ 9.09% |
| EMIS | Emmis Acquisition Corp. | USD 10.15 | ▲ 0.2% |
| CVAS | CREATIVE VISTAS INC | USD 0 | ▲ 0% |
| ERGO | Entia Biosciences Inc. | USD 0 | ▲ 0% |
| BNT | Brookfield Wealth Solutions Ltd | USD 45.47 | ▲ 2.34% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:30 UTC. This page is informational and not investment advice.